Phcog.Net logo

BROWSE ALL JOURNALS

    SEE ALL 6 JOURNALS
    Article

    A Novel Citrus medica Gel for the Treatment of Experimental Osteoarthritis: A Preclinical Study

    Snehalakshmi Kavacheri Subramaniam1★, Umamaheswari Anbarasu1, Bhuvaneswari Krishnamurthy1, Manashaa Gnanaprakasam Poonguzhali1★ Corresponding author

    1. 1Department of Pharmacology, PSG Institute of Medical Sciences and Research, Coimbatore, Tamil Nadu, India.

    CORRESPONDENCE

    Snehalakshmi Kavacheri Subramaniam

    Department of Pharmacology, PSG Institute of Medical Sciences and Research, Coimbatore, Tamil Nadu, India.

    snehalakshmi2612@gmail.com

    Received: 02-07-2025; Revised: 27-11-2025; Accepted: 02-01-2026.

    Volume 17, Issue 4 · pp. 544–552 · PUBLISHED 2026 · DOI: 10.1177/0976500X261417415

    View on J Pharmacol. Pharmacother. original site ↗

    ABSTRACT

    Background: Osteoarthritis (OA) is the most common form of arthritis affecting the elderly and obese population, and requires long-term medical management. Inflammatory pathways, possibly initiated by tissue damage and stress are involved in the pathogenesis of OA. Citrus medica Linn., known for its anti-inflammatory and analgesic properties, has been the focus of management of OA in recent years. Objectives: To explore the therapeutic potential of Citrus medica gel in Wistar Albino rat OA model with standard Aceclofenac gel. Materials and Methods: An experimental interventional animal study was conducted in which OA was induced in 24 male Wistar Albino rats (12-week-old) using monosodium iodoacetate. The animals were observed for 1 week for signs of joint inflammation. They were then divided into four groups. Group A (standard) received Aceclofenac gel twice daily (BD) for 4 weeks. Group B received C. medica gel (0.2 g, 0.33% w/w) once daily (OD). Group C received C. medica gel (0.2 g, 0.33% w/w) BD, and Group D was kept as a disease control throughout the study. The results were compared between groups using one-way analysis of variance (ANOVA). Results: The double-dose C. medica gel regimen displayed a significant and earlier reduction in ankle joint circumference (ANOVA, p value < .001). Pain relief was observed, as evidenced by a favorable reversal of the arthritic index and score compared to the standard treatment. Conclusion: This study highlights the potential of C. medica gel in reducing inflammation and pain associated with OA. These findings warrant further investigation through clinical trials.

    KEYWORDS

    Open in new tab

    REFERENCES

    As published

    Showing references and in-text citations exactly as published.

      Cite this article

      SELECT FORMAT

      Subramaniam, S. K., Anbarasu, U., Krishnamurthy, B., & Poonguzhali, M. G. (2026). A Novel Citrus medica Gel for the Treatment of Experimental Osteoarthritis: A Preclinical Study. Journal of Pharmacology and Pharmacotherapeutics, 17(4), 544–552. https://doi.org/10.1177/0976500X261417415